百利天恒通过聆讯，成都企业迎赴港上市热潮

Core Viewpoint - Hong Kong is experiencing a listing boom, with companies like Baile Tianheng preparing for their IPOs, reflecting a strong interest from Chengdu enterprises in accessing international capital markets [1][8]. Group 1: Market Activity - Baile Tianheng has passed the listing hearing on the Hong Kong Stock Exchange, with Chengdu's total number of listed companies expected to reach 28 [1]. - Numerous institutions and enterprises actively participated in the "Rongyi Shang" event, indicating a high level of interest in Hong Kong listings [3]. - The scale of participation in the event this year has significantly increased compared to last year, showcasing the enthusiasm of Chengdu enterprises for listing in Hong Kong [3]. Group 2: Sector Insights - The event featured specialized sessions for biopharmaceutical and technology/consumer sectors, with over a hundred representatives from enterprises and financial institutions attending [3][5]. - Key insights were shared regarding the opportunities and challenges faced by companies seeking to list in Hong Kong, particularly in the biopharmaceutical sector [5][7]. - Legal experts discussed critical points encountered by enterprises during the listing process, emphasizing the importance of legal support for technology and consumer companies [5]. Group 3: Investment Opportunities - Investment institutions highlighted the opportunities presented by listing in Hong Kong, particularly for Chengdu enterprises looking to expand internationally [8]. - Several Chengdu companies, including Guoxing Aerospace and Xinyue Holdings, have submitted applications for Hong Kong listings this year, indicating a trend of local firms seeking to leverage international capital markets [8]. - As of now, Chengdu has 122 A-share listed companies, 27 listed in Hong Kong, and 5 in the US, with the total expected to reach 154 following Baile Tianheng's listing [8].